CSR News Stories
German medical firm Bayer is to pay nearly $100m to settle a lawsuit alleging that the company bribed suppliers of medicines for diabetes into switching from competitor's products.
The European Commission has fined five oil and chemical companies for fixing the price of rubber used for tyres, including Italy's Eni which received the largest fine at 272m euros.
A new report by Consumers International has accused top European pharmaceutical companies of using irresponsible marketing to promote their products.
An antitrust lawsuit against Monsanto has been given the green light to go ahead by a US District Court judge. Other companies are also in the firing line, including DuPont, Bayer AG and Syngenta.
German drugs and chemicals firm Bayer AG has won a key legal victory as a US Federal Court has denied a proposed class action on the impacts of the company's withdrawn drug Baycol.
Roche Holding AG has said that it will appeal a $10m fine in Italy for alleged antitrust activity on diabetes tests. The company - one of five fined - insisted that it had not been engaged in wrongdoing.
Bayer's fortunes seem to have improved considerably after a second court win over its cholesterol drug Baycol substantially revised downwards the expectations of its legal liabilities.
A jury in South Texas has found Baycol innovent of marketing and design defects in its cholesterol drug, Baycol, which it pulled from the market last year.
Some senior executives at Bayer have been accused of having known for some time that the company's anti-cholesterol drug Baycol had serious problems before withdrawing it from sale.
The UN Security Council has been urged by a specialist panel to impose financial sanctions against companies who it accuses of plundering the wealth of the Democratic Republic of Congo.
ExxonMobil and Shell are being investigated by the European Commission for alleged price-fixing in the asphalt sector.
Bayer A.G., the German pharmaceutical and chemical company, has withdrawn their successful new cholesterol-lowering drug Baycol in the light of growing evidence of side-effects which may already have led to 31 deaths in the US.
Showing 1 - 12 of 12 results.
The Business Respect email newsletter has been produced since 2001 to give news and commentary on CSR worldwide
See the archive of past issues
In a recent article, the BBC's economics editor Robert Peston highlighted the fact that in 2012 the chances are that the economy - punch drunk as it is from the various flavours of debt crisis it has been pummelled with over the course of the year - will be hit by the collapse of a major bank and / or government.